AUTHOR=Pillonetto Marcelo , Jordão Regiane Tigulini de Souza , Andraus Gabriel Savogin , Bergamo Ricardo , Rocha Fabiano Barreto , Onishi Mayara Caroline , Almeida Bernardo Montesanti Machado de , Nogueira Keite da Silva , Dal Lin Amanda , Dias Viviane Maria de Carvalho Hessel , Abreu André Luiz de TITLE=The Experience of Implementing a National Antimicrobial Resistance Surveillance System in Brazil JOURNAL=Frontiers in Public Health VOLUME=8 YEAR=2021 URL=https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2020.575536 DOI=10.3389/fpubh.2020.575536 ISSN=2296-2565 ABSTRACT=
Antimicrobial resistance (AMR) is a major public health threat of global proportions, which has the potential to lead to approximately ten million deaths per year by 2050. Pressured by this wicked problem, in 2014, the World Health Organization launched a call for member states to share AMR data through the implementation of the Global Antimicrobial Resistance Surveillance System (GLASS), to appropriately scale and monitor the general situation world-widely. In 2017, Brazil joined GLASS and, in 2018, started its own national antimicrobial surveillance program (BR-GLASS) to understand the impact of resistance in the country. We compiled data obtained from the complete routine of three hospitals' microbiology labs during the year of 2018. This pilot data sums up to 200,874 antimicrobial susceptibility test results from 11,347 isolates. It represents 119 different microorganisms recovered from 44 distinct types of clinical samples. Specimens came from patients originating from 301 Brazilian cities, with 4,950 of these isolates from presumed Healthcare-Associated Infections (HAIs) and the other 6,397 community-acquired cases. The female population offered 58% of the collected samples, while the other 42% were of male origin. The urinary tract was the most common topography (6,372/11,347 isolates), followed by blood samples (2,072/11,347). Gram-negative predominated the bacterial isolates: